|
FOR RELEASE ON |
10 May 2023 |
IP Group - Director/PDMR share purchases
IP Group plc (LSE: IPO) ("IP Group" or "the Group" or "the Company"), which invests in breakthrough science and innovation companies with the potential to create a better future for all, has been notified that on 5 May 2023, Christopher Glasson, Finance Director and a PDMR, purchased a total of 49,690 Shares of 2p each as outlined in the table below.
|
Name |
Number of shares acquired |
Price per share |
Resulting beneficial interest |
|
Christopher Glasson |
49,690 |
55.12p |
204,013 |
The notification below, made in accordance with the requirements of article 19 of the UK Market Abuse Regulation, provides further detail.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.
|
1 |
Details of the person discharging managerial responsibilities / person closely associated |
|||||
|
a) |
Name |
Christopher Glasson |
||||
|
2 |
Reason for the notification |
|||||
|
a) |
Position/status |
Finance Director (PDMR)
|
||||
|
b) |
Initial notification/Amendment |
Initial Announcement |
||||
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||
|
a) |
Name |
IP Group plc |
||||
|
b) |
LEI |
213800HG22UM138WFG43 |
||||
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||
|
a) |
Description of the financial instrument, type of instrument Identification code |
Ordinary Shares of 2p each in IP Group plc
ISIN: GB00B128J450 |
||||
|
b) |
Nature of the transaction |
Purchase of shares |
||||
|
c) |
Price(s) and volume(s) |
|
||||
|
d) |
Aggregated information - Aggregated volume - Price |
49,690 55.12 pence per share |
||||
|
e) |
Date of the transaction |
5 May 2023 |
||||
|
f) |
Place of the transaction |
London Stock Exchange, Main Market |
||||
For more information, please contact:
|
IP Group plc |
www.ipgroupplc.com |
|
Greg Smith, Chief Executive Officer David Baynes, Chief Financial and Operating Officer Liz Vaughan-Adams, Communications |
+44 (0) 20 7444 0050
+44 (0) 20 7444 0062/+44 (0) 7967 312125 |
|
Portland |
|
|
Vic Wallin Alex Donaldson |
+44 (0) 7973 823119 +44 (0) 7516 729702 |
Notes for editors
About IP Group
IP Group accelerates the impact of science for a better future. As the most active UK based, early stage science investor, we develop and support some of the world's most exciting businesses in deeptech, life sciences and cleantech (led by Kiko Ventures). Through Parkwalk, the UK's largest growth EIS fund manager, we also back world-changing innovation emerging in leading universities and research institutions. Our specialist investment team combines sector expertise with an international approach. Together we have a strong track record of success, having backed high-profile companies including Oxford Nanopore Technologies plc, First Light Fusion, Hysata, and Oxbotica. IP Group is listed on the Main Market of the London Stock Exchange under the code IPO.
For more information, please visit our website at www.ipgroupplc.com.
ENDS
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
